REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/19/2026
Trademark type
Combined
Nice classes
35, 45
Filing date
08/07/2019
Registration date
05/18/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/28/2019
First use in commerce
10/28/2019
Drawing code
3
Owner type
03
Owner location
West Lafayette, IN, US
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized design comprised of two diagonal intersecting pill capsules forming a heart shaped arrow design on the left side and creating an "x" shape; the design element appears to the left of the wording "Parsolex"; centered underneath the design and "Parsolex" wording appears the wording "PARTNER SOLUTIONS EXCELLENCE".
Holders and representatives
Holders
Parsolex GMP Center, Inc.
Representatives
Jill J. Chalmers BRYAN CAVE LEIGHTON PAISNER LLP
Technical classification
Nice Classes
Class 35Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Market assessment services; consulting servicesproviding market research and business analysis services in the pharmaceuticalmedical and healthcare fields; business consulting and planning services in the field of pharmaceuticalsmedicine and healthcare; business consulting and planning services in the field of the commercialization of pharmaceuticalsmedicines and healthcare products; business consulting services relating to product distributionoperations management serviceslogisticsreverse logisticssupply chainproduction systems and distribution solutions; consulting in the fields of sales methodssales managementsales improvement; business consultation; business administration consultation services; business operation consultation services; business consulting services in the field of pharmaceutical manufacturingpharmaceutical packagingdistribution; business consulting in the pharmaceutical productsmedical and healthcare industries; business consultingbusiness managementbusiness advisory services; marketing consulting services in the field of pharmaceuticalsmedicine and healthcare; business marketing consulting services; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; branding and marketing services for others in the field of pharmaceuticalmedicalhealthcare industries; regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; advertising of custom services for pharmaceutical formulation designdesign of processes to transform inorganic and organic substancesscale-up of pharmaceutical manufacturing processespharmaceutical technology transfermanufacture of pharmaceuticalschemical and physical evaluation of pharmaceuticals for others; distributorship services of pharmaceutical and medical products for others; commercialization of pharmaceuticals and medical products for others
Class 45
Consulting services in the field of regulatory compliance in the pharmaceuticalmedical and healthcare industries; regulatory services for otherstracking and monitoring regulatory requirements in the field of the pharmaceuticalmedicalhealthcare industries for regulatory compliance purposes
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/16/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/15/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/02/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/01/2021
IUAF
USE AMENDMENT FILED
03/17/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/17/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/28/2020
PUBO
PUBLISHED FOR OPPOSITION
07/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/24/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/16/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/16/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/16/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/16/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/16/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/10/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/22/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/22/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/22/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2020
ALIE
ASSIGNED TO LIE
04/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
10/31/2019
GPRA
PRIORITY ACTION E-MAILED
10/31/2019
CPRA
PRIORITY ACTION WRITTEN
10/31/2019
DOCK
ASSIGNED TO EXAMINER
10/16/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/24/2019
NWAP
NEW APPLICATION ENTERED
08/10/2019
Continuous trademark protection
Get notified about every new filing that threatens X PARSOLEX PARTNER SOLUTIONS EXCELLENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.